Here are three keynotes on the company’s financial performance in the third quarter of FY 2016.
1. U.S. sales showed a 6 percent increase, hitting $1.1 billion in the third quarter of FY 2016, while international sales reached 1.5 billion, representing a 1 percent increase from the same period the year prior.
2. The company’s sales of hospital products marked a 2 percent increase in the third quarter of FY 2016 to reach $1.6 billion, while renal sales hit $977 million, showing a 4 percent increase from the third quarter of 2015.
3. After a strong financial performance for the first three quarters of the year, Baxter is updating its financial outlook for 2016, expecting higher total sales growth and earnings.
More articles on supply chain:
GSK seeks approval of shingles vaccine: 4 things to know
Where Trump, Clinton stand on medical device tax
FDA approves Immucor’s device to detect sickle cell trait in blood
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
